Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONRC-10000751Phase 4Completed
Phase 4, open-label trial of linezolid in Gram-positive bacterial infection (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Plasma drug concentration. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONRC-10000751.